{
  "id": 7790300,
  "title": "FDA approves pioneering breast cancer drug that nips resistance in the bud",
  "url": "https://urgent.news/2026/09/16/fda-approves-pioneering-breast-cancer-drug-that-nips-resistance-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-16T00:00:00.000Z",
  "source": {
    "name": "Nature Biotechnology",
    "slug": "nature-biotechnology",
    "url": "https://www.nature.com/articles/s41587-026-03333-8"
  },
  "original_language": "en",
  "account": null,
  "summary": "Nature Biotechnology, Published online: 16 September 2026; doi:10.1038/s41587-026-03333-8 A breast cancer drug linked with a test to detect ESR1 mutations in circulating tumor DNA is one of a wave of new drugs developed to tackle resistance to estrogen-receptor-targeted therapies.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "FDA approves Lilly's oral SERD combo for second-line breast cancer therapy",
        "url": "https://urgent.news/2026/09/18/fda-approves-lillys-oral-serd-combo-for-second-line-breast-cancer",
        "published": "2026-09-18T19:32:11.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}